FR2209546B1 - - Google Patents
Info
- Publication number
- FR2209546B1 FR2209546B1 FR7343191A FR7343191A FR2209546B1 FR 2209546 B1 FR2209546 B1 FR 2209546B1 FR 7343191 A FR7343191 A FR 7343191A FR 7343191 A FR7343191 A FR 7343191A FR 2209546 B1 FR2209546 B1 FR 2209546B1
- Authority
- FR
- France
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/22—Cyclohexane rings, substituted by nitrogen atoms
- C07H15/222—Cyclohexane rings substituted by at least two nitrogen atoms
- C07H15/226—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings
- C07H15/228—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings attached to adjacent ring-carbon atoms of the cyclohexane rings
- C07H15/232—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings attached to adjacent ring-carbon atoms of the cyclohexane rings with at least three saccharide radicals in the molecule, e.g. lividomycin, neomycin, paromomycin
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Communicable Diseases (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Cephalosporin Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US31245272A | 1972-12-06 | 1972-12-06 |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2209546A1 FR2209546A1 (nl) | 1974-07-05 |
FR2209546B1 true FR2209546B1 (nl) | 1977-09-02 |
Family
ID=23211510
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR7343191A Expired FR2209546B1 (nl) | 1972-12-06 | 1973-12-04 |
Country Status (4)
Country | Link |
---|---|
JP (1) | JPS5719120B2 (nl) |
DE (1) | DE2360946A1 (nl) |
FR (1) | FR2209546B1 (nl) |
GB (1) | GB1456674A (nl) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999058126A1 (en) * | 1998-05-11 | 1999-11-18 | The Endowment For Research In Human Biology, Inc. | Use of neomycin for treating angiogenesis-related diseases |
WO2006052930A1 (en) | 2004-11-05 | 2006-05-18 | Isis Pharmaceuticals, Inc. | Antimicrobial 2-deoxystreptamine compounds |
ES2707787T3 (es) | 2005-12-02 | 2019-04-05 | Ionis Pharmaceuticals Inc | Análogos antibacterianos de aminoglucósido 4,5-sustituidos que tienen sustituyentes múltiples |
CA2684957A1 (en) * | 2007-04-10 | 2008-10-16 | Achaogen Inc. | Antibacterial 1,4,5-substituted aminoglycoside analogs |
WO2010030690A1 (en) | 2008-09-10 | 2010-03-18 | Isis Pharmaceuticals, Inc. | Antibacterial 4,6-substituted 6', 6" and 1 modified aminoglycoside analogs |
WO2010030704A2 (en) | 2008-09-10 | 2010-03-18 | Achaogen, Inc. | Antibacterial aminoglycoside analogs |
WO2010042851A1 (en) | 2008-10-09 | 2010-04-15 | Achaogen, Inc. | Antibacterial aminoglycoside analogs |
WO2010042850A1 (en) | 2008-10-09 | 2010-04-15 | Achaogen, Inc. | Antibacterial aminoglycoside analogs |
WO2011044501A2 (en) | 2009-10-09 | 2011-04-14 | Achaogen, Inc. | Antibacterial aminoglycoside analogs |
CN103282370A (zh) | 2010-11-17 | 2013-09-04 | 尔察祯有限公司 | 抗菌氨基糖苷类类似物 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK122735B (da) * | 1968-03-25 | 1972-04-04 | Parke Davis & Co | Fremgangsmåde til fremstilling af et antibakterielt virksomt stof, ambutyrosin, dets komponenter ambutyrosin A og B eller syreadditionssalte, eller tetra-N-acetylderivater eller tetra-N-methansulfonatderivater deraf. |
-
1973
- 1973-12-04 FR FR7343191A patent/FR2209546B1/fr not_active Expired
- 1973-12-05 GB GB5642173A patent/GB1456674A/en not_active Expired
- 1973-12-05 JP JP13525473A patent/JPS5719120B2/ja not_active Expired
- 1973-12-06 DE DE2360946A patent/DE2360946A1/de not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
DE2360946A1 (de) | 1974-06-20 |
GB1456674A (en) | 1976-11-24 |
JPS5719120B2 (nl) | 1982-04-20 |
FR2209546A1 (nl) | 1974-07-05 |
JPS4992044A (nl) | 1974-09-03 |
Similar Documents
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |